Latest Breaking News On - Analyst recommendations for phathom pharmaceuticals - Page 1 : comparemela.com

Phathom Pharmaceuticals (NASDAQ:PHAT) Coverage Initiated by Analysts at Stifel Nicolaus

Stifel Nicolaus initiated coverage on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report released on Friday morning, MarketBeat.com reports. The firm issued a buy rating and a $24.00 price objective on the stock. Separately, Needham & Company LLC restated a buy rating and set a $26.00 price objective on shares of Phathom […]

United statesMolly hendersonTerrie curranStifel nicolausZurcher kantonalbank zurich cantonalbankPhathom pharmaceuticalsPhathom pharmaceuticals incChina universal asset management coAnalyst recommendations for phathom pharmaceuticalsPhathom pharmaceuticals tradingNeedham companySecurities exchange commissionKlingman associatesHedge funds weigh in on phathom pharmaceuticalsNews ratings for phathom pharmaceuticals dailyPhathom pharmaceuticals company profile

Phathom Pharmaceuticals (NASDAQ:PHAT) Earns Buy Rating from Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report issued on Friday morning, Benzinga reports. The firm currently has a $26.00 target price on the stock. Separately, Stifel Nicolaus assumed coverage on shares of Phathom Pharmaceuticals in a research report on Friday. They set […]

United statesTerrie curranStifel nicolausMolly hendersonInvesco ltdNews ratings for phathom pharmaceuticals dailyVanguard group incNeedham companyAnalyst recommendations for phathom pharmaceuticalsPhathom pharmaceuticalsAlgert globalChina universal asset management coPhathom pharmaceuticals incSecurities exchange commissionSg americas securitiesPhathom pharmaceuticals trading

Needham & Company LLC Reaffirms Buy Rating for Phathom Pharmaceuticals (NASDAQ:PHAT)

Needham & Company LLC Reaffirms Buy Rating for Phathom Pharmaceuticals (NASDAQ:PHAT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausMolly hendersonZurcher kantonalbank zurich cantonalbankTerrie curranPhathom pharmaceuticals tradingYork mellon corpInsider transactions at phathom pharmaceuticalsSg americas securitiesInstitutional investors weigh in on phathom pharmaceuticalsPhathom pharmaceuticals incPrincipal financial group incPhathom pharmaceuticalsAnalyst recommendations for phathom pharmaceuticalsNeedham companyBarclays plc

Brokerages Set Phathom Pharmaceuticals, Inc (NASDAQ:PHAT) PT at $23 00

Brokerages Set Phathom Pharmaceuticals, Inc (NASDAQ:PHAT) PT at $23 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesMolly hendersonGoldman sachs group incPhathom pharmaceuticals incPhathom pharmaceuticals company profileNews ratings for phathom pharmaceuticals dailyPhathom pharmaceuticalsDecheng capitalAnalyst recommendations for phathom pharmaceuticalsInstitutional investors weigh in on phathom pharmaceuticalsNeedham companyCo ltd takedaSecurities exchange commissionInsider activity at phathom pharmaceuticalsDynamic technology lab private ltdPhathom pharmaceuticals price performance

Phathom Pharmaceuticals, Inc (NASDAQ:PHAT) Given Consensus Recommendation of Moderate Buy by Brokerages

Phathom Pharmaceuticals, Inc (NASDAQ:PHAT) Given Consensus Recommendation of Moderate Buy by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMolly hendersonKennedy capital managementCo ltd takedaCarlyle group incPhathom pharmaceuticals incSecurities exchange commissionPhathom pharmaceuticals stock performanceGoldman sachs groupNews ratings for phathom pharmaceuticals dailyAnalyst recommendations for phathom pharmaceuticalsInsider transactions at phathom pharmaceuticalsPhathom pharmaceuticalsInstitutional trading of phathom pharmaceuticalsDecheng capitalNeedham company